Formulex Pharma Innovations · raw details

Nanotechnology-based Drug Delivery and Formulation · Ness Ziona · Founded 2001

active Seed ← back to profile

Highlights

IIA supported (ever)1 patent

About

Nanotechnology-based Drug Delivery and Formulation

Formulex Pharma Innovations continues the activities of SoluBest Ltd in the field of nanotechnology-based drug delivery and formulation. Formulex generates innovative formulation solutions for Israeli and global clients in diversified fields such as biopharmaceuticals, nutraceuticals, and agrochemicals. The formulation development is accompanied by full analytical support and stability studies. Formulex has been developing more than 10 medical cannabis products using its patented Solumer and generic technologies. Five of the products are in the clinical and commercial stages. Solumer was developed by Solubest to maximize the solubility, bioavailability, and physical stability of drug substances utilizing sub-micron-particle engineering. The company designed solid dispersion formulations through a proprietary spray drying process. The technology is proven in preclinical and clinical trials to enhance bioavailability and drug substance performance. Formulex is able to develop and produce under GMP conditions oral, topical, and inhaled dosage forms for clinical phases one and two.

Identity

NameFormulex Pharma Innovations
Slugsolubest
Former namesSoluBest
Type / kindstartup
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6V05oLDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityNess Ziona
HQ addressEinstein Street 18, Ness Ziona, Israel

Web & social

Websitehttps://www.formulex-pi.com/
Careers pagehttps://www.formulex-pi.com
LinkedInhttps://www.linkedin.com/company/1044256

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug Delivery
Technologies
Materials & SubstancesRaw MaterialsBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
nanotechnologybiotechnologydrug-designfoodtechpharmaceuticalsanimal-healthoral-drugsmedical-cannabisdrug-delivery

Funding

Total raised$55.0M
Current stageSeed

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}